Selank

Batch #543100Batch #543100
Report #53453Report #53453
Tested at 8.56mgTested at 8.56mg
Size: 10mg
Visa Mastercard American Express Discover Apple Pay Google Pay
Ships by ...
Flag
FREE Shipping

RESEARCH USE ONLY
These compounds are NOT intended for human consumption, clinical use, or veterinary applications. We are not affiliated with any pharmaceutical companies or their commercial medications. By placing an order, you certify these materials will be used exclusively for in vitro testing and laboratory experimentation only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.

About Selank

Selank is a synthetic peptide derived from tuftsin a naturally occurring immune molecule. It has been studied for its potential role in modulating cognitive processes including memory and learning. Research has also explored its effects on stress-related pathways sensory perception and its broader implications in neurobiological functions.

Product Specifications

Selank Lyophilized Powder in 3ml vial.

Application

Research peptide with potential in cognitive studies

Appearance

Solid, white powder in 3mL glass ampule

Chemical Formula

C33H57N11O9

PubChem CID

11765600

CAS Number

129954-34-3

Molecular Weight

751.878 g/mol

Synonyms

SEL-729, TP-7, Thr-Lys-Pro-Arg-Pro-Gly-Pro

Storage

Store Selank 5mg at ≤6°C, sealed, away from heat, light, and moisture.

Selank Research

1. Overview   

Selank is a synthetic version of the natural peptide tuftsin, originally developed in Russia as an anti-anxiety and cognitive-enhancing compound. Research has explored its potential to reduce stress, support mental performance, and regulate immune system activity.

2. Clinical Overview & Uses 

Selank has been studied in people with anxiety-asthenic disorders and with generalized anxiety. It is used intranasally in a variety of clinical applications in Russia and Eastern Europe. It has actions similar to mild anxiolytics but is non-sedative and non-addictive.

3. Key Findings from Human Trials   

One clinical study included 62 patients with generalized anxiety disorder (GAD) or neurasthenia. About half of those received Selank (the rest got a standard anti-anxiety medicine). The study found that Selank reduced anxiety in a way similar to the control drug, but also improved fatigue and cognitive speed / energy levels more than the standard treatment. PubMed

One other study examined immune / cytokine effects of Selank in individuals with anxiety-asthenic disorders. By 14 days of treatment, Selank had shifted the balance of the immune signaling molecules (Th1 Th2cytokines) and decreased signs of inflammation in study participants, indicating it promotes immune regulation response in stressed or anxious subjects.  PubMed

Selank has been evaluated in women during menopause /emotional. There is one report of its use for curing “autonomic and psychoemotional disorders” in women with climacteric syndrome.  Eco-Vector Journals Portal

4. Mechanism & Effects on Brain / Immune Function

Selank is thought to affect the immune system (cytokines) and brain chemistry (neurotransmitters). For instance, it may shift immune balance away from overactive inflammation and toward more regulated responses. PubMed

There's also genetic / molecular evidence (in animals / lab) that Selank alters the activity of GABA related genes in the brain, acting a bit like weaker forms of anti-anxiety medications (benzodiazepines), but without some of their side-effects. Frontiers   

5. Safety & Tolerability (Human Evidence)    

Good tolerability has been reported in human trials that are available. Serious side effects in the patients studied are not widely reported. Because Selank is typically utilized in brief periods (days to weeks) for anxiety aid, long-term safety data is very limited.

6. Bottom Line   

Selank appears to be a very positive peptide with human trial data proving (in Russia/Eastern Europe) its pro-anxiolytic (anxiety-reducing), stress-reducing and immunomodulating properties without being particularly sedative or habit forming. Better quality, larger trials would further confirm its effects in more diverse populations.

You ask,
we answer.